SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,280 | -90.0% | 16,000 | -77.3% | 0.00% | -100.0% |
| Q2 2023 | $3,308,374 | +1175.6% | 70,361 | +934.7% | 0.01% | +140.0% |
| Q4 2022 | $259,352 | -27.1% | 6,800 | -25.3% | 0.01% | -28.6% |
| Q3 2022 | $356,000 | -66.8% | 9,100 | -72.6% | 0.01% | -76.7% |
| Q2 2022 | $1,072,000 | -66.7% | 33,199 | -56.1% | 0.03% | -70.0% |
| Q4 2021 | $3,219,000 | +507.4% | 75,679 | +310.3% | 0.10% | -14.5% |
| Q1 2020 | $530,000 | -94.4% | 18,445 | -72.8% | 0.12% | -79.4% |
| Q3 2019 | $9,512,000 | +3358.9% | 67,799 | +4419.9% | 0.57% | +1790.0% |
| Q2 2019 | $275,000 | – | 1,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |